Role of Bub1 in SV40 large T antigen mediated transformation and replication
Bub1 在 SV40 大 T 抗原介导的转化和复制中的作用
基本信息
- 批准号:7683275
- 负责人:
- 金额:$ 37.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-10 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffectAneuploidyBindingBinding ProteinsBiological ModelsCell CycleCell divisionCellsChromosomal InstabilityChromosome abnormalityChromosomesComplexCytokinesisDNADNA DamageDNA Tumor VirusesDNA biosynthesisElementsExhibitsGenomeHumanImpairmentIn VitroKinetochoresLarge T AntigenLeadLife Cycle StagesLightLinkLiteratureMalignant - descriptorMalignant ConversionMalignant NeoplasmsMapsMediatingMicroscopyMitosisMitoticModelingMolecularMonitorMutateMutationNatureNuclearOncogenicPathway interactionsPhenotypePhosphorylationPhosphotransferasesPloidiesProcessProtein p53RNA InterferenceRegulationRoleSignal TransductionSimian virus 40Sister ChromatidSiteTP53 geneTetraploidyTimeViralViral Tumor AntigensVirusantigen bindingattenuationbasecell growthcellular targetinggain of functiongenetic analysisin vivoinsightnovelprematurepublic health relevanceresponsescaffoldsenescencesialosyl-T antigentumortumorigenesisviral DNA
项目摘要
DESCRIPTION (provided by applicant): SV40 large T antigen (LT) is a powerful model to study DNA replication and malignant transformation. We have identified an interaction of LT with the mitotic regulator Bub1. Bub1 is critical for preserving genome integrity. It primarily acts at the spindle checkpoint, where it serves a critical function in monitoring tension and attachment at sister chromatid kinetochores. Bub1 is mutated in certain human cancers characterized by aneuploidy. LT binding to Bub1 leads to attenuation of the spindle checkpoint. We hypothesize that binding of Bub1 to LT accounts for some of LT's ability to destabilize the host genome, in particular the ability to induce tetraploidy. Genetic analysis shows that LT binding to Bub1 is required not only for oncogenic transformation but also for viral DNA replication. Our analysis further demonstrates that LT binding to Bub1 is linked to p53 stabilization, which is likely a consequence of a DNA damage response. Our observations are consistent with a model whereby LT acts as a molecular scaffold to direct Bub1 to phosphorylate targets such as p53. The interaction with Bub1 suggests novel roles for LT that may shed light on how it causes chromosome aberrations, stabilization of p53 and transformation. We propose the following aims to study the interaction in detail: 1. Determine mechanistically how LT transforms via Bub1 and the potential contribution of a p53 gain of function 2. Characterize how LT uses Bub1 to induce tetraploidy and DNA damage responses 3. Elucidate how LT promotes viral replication via Bub1 binding. PUBLIC HEALTH RELEVANCE: Studies of the large T antigen of the SV40 DNA tumor virus have provided significant insight on basic mechanisms required for tumor induction and accurate duplication of DNA molecules (replication). Critical cellular targets such as the p53 tumor suppressor were first identified using this model. We have characterized a novel binding partner for T antigen called Bub1. Interestingly, Bub1 closely monitors and safeguards cell division, a process that T antigen has long been suspected to disrupt and thereby cause chromosomal abnormalities. Bub1 mutations are found in certain human cancers also characterized by chromosomal abnormalities. Our proposal will investigate how mechanistically T antigen binding to Bub1 is required for malignant conversion and replication. In the process, we expect to gain a better understanding of normal Bub1 function, and how its compromise facilitates tumorigenesis.
描述(申请人提供):SV40大T抗原(LT)是研究DNA复制和恶性转化的强大模型。我们已经确定了LT与有丝分裂调节因子Bub1的相互作用。Bub1对保持基因组完整性至关重要。它主要在纺锤体检查点起作用,在那里它在监测姐妹染色单体着丝点的张力和附着方面起关键作用。Bub1在某些以非整倍体为特征的人类癌症中发生突变。LT与Bub1结合导致纺锤体检查点的衰减。我们假设,Bub1与LT的结合在一定程度上解释了LT破坏宿主基因组稳定性的能力,特别是诱导四倍体的能力。遗传分析表明,LT与Bub1的结合不仅是致癌转化所必需的,也是病毒DNA复制所必需的。我们的分析进一步表明,LT与Bub1的结合与p53的稳定有关,这可能是DNA损伤反应的结果。我们的观察结果与LT作为分子支架指导Bub1磷酸化p53等靶标的模型一致。与Bub1的相互作用提示了LT的新作用,可能揭示了它如何导致染色体畸变、p53的稳定和转化。我们提出以下目标来详细研究这种相互作用:1。确定LT如何通过Bub1转化的机制以及p53功能获得的潜在贡献2。描述LT如何使用Bub1诱导四倍体和DNA损伤反应3。阐明LT如何通过Bub1结合促进病毒复制。公共卫生相关性:对SV40 DNA肿瘤病毒的大T抗原的研究为肿瘤诱导和DNA分子精确复制(复制)所需的基本机制提供了重要的见解。关键的细胞靶点,如p53肿瘤抑制因子,首次使用该模型确定。我们已经描述了一种新的T抗原结合伙伴,称为Bub1。有趣的是,Bub1密切监视和保护细胞分裂,这一过程长期以来一直被怀疑是T抗原破坏的,从而导致染色体异常。在某些以染色体异常为特征的人类癌症中发现了Bub1突变。我们的建议将研究T抗原与Bub1结合的机制是如何需要恶性转化和复制的。在这个过程中,我们期望更好地了解正常的Bub1功能,以及它的妥协如何促进肿瘤的发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ole Gjoerup其他文献
Ole Gjoerup的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ole Gjoerup', 18)}}的其他基金
Role of Bub1 in SV40 large T antigen mediated transformation and replication
Bub1 在 SV40 大 T 抗原介导的转化和复制中的作用
- 批准号:
8384909 - 财政年份:2008
- 资助金额:
$ 37.33万 - 项目类别:
Role of Bub1 in SV40 large T antigen mediated transformation and replication
Bub1 在 SV40 大 T 抗原介导的转化和复制中的作用
- 批准号:
7502382 - 财政年份:2008
- 资助金额:
$ 37.33万 - 项目类别:
Role of Bub1 in SV40 large T antigen mediated transformation and replication
Bub1 在 SV40 大 T 抗原介导的转化和复制中的作用
- 批准号:
7911859 - 财政年份:2008
- 资助金额:
$ 37.33万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 37.33万 - 项目类别:
Operating Grants